Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Delta-1 enhances marrow and thymus repopulating ability of human CD34+CD38– cord blood cells
Kohshi Ohishi, Barbara Varnum-Finney, Irwin D. Bernstein
Kohshi Ohishi, Barbara Varnum-Finney, Irwin D. Bernstein
View: Text | PDF
Article

Delta-1 enhances marrow and thymus repopulating ability of human CD34+CD38– cord blood cells

  • Text
  • PDF
Abstract

Research Article

Authors

Kohshi Ohishi, Barbara Varnum-Finney, Irwin D. Bernstein

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
I-Delta1ext-myc promoted T/NK cell differentiation, which was enhanced b...
I-Delta1ext-myc promoted T/NK cell differentiation, which was enhanced by IL-7. Culture plates were precoated with anti-myc 9E10 F(ab′)2 and CH-296. (a) CD34+CD38– precursors (400 cells per well) were cultured for 3 weeks in serum-free medium containing 5GF with or without IL-7 (100 ng/ml) and either 1 μg/ml of Delta1ext-myc (I-Delta) or the same volume of control medium (Control). Data are representative of four independent experiments. Numbers in corners are the percentage of gated events within that quadrant. cy CD3, cytoplasmic CD3. (b) RNA was extracted from freshly obtained peripheral T cells (lane 1), freshly obtained peripheral granulocytes (lane 2), fresh CD34+CD38– cells (lane 3), cells cultured for 3 weeks with I-Delta1ext-myc (lane 4), cells cultured with I-Delta1ext-myc and IL-7 (lane 5), cells cultured in control medium (lane 6), and cells cultured in control medium and IL-7 (lane 7). Equal amounts of RNA were subjected to RT-PCR, followed by electrophoresis on an agarose gel and ethidium bromide staining (see Methods). (c) CD34+CD38– precursors (400 cells per well) were cultured for 5 weeks with 5GF, with or without IL-7 (100 ng/ml), and either I-Delta1ext-myc or control medium. Cells were stained with FITC-conjugated CD7 (4H9) and PE-conjugated CD34 antibody. Mean numbers of CD34+ cells, CD34+CD7+ cells, and CD34–CD7+ cells in six wells are shown. Data are representative of three independent experiments. MW, molecular weight.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts